Skip to content

Angioedema Hereditary 8 C5543528

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition that causes recurrent episodes of severe swelling in various body parts. These episodes can be life-threatening if the throat is affected. Treatment focuses on prevention and prompt management of acute swelling attacks.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pharyngeal swelling

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Abdominal pain

(gastrointestinal)

Scalp swelling

(integumentary)

Erythema marginatum

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

C1-inhibitor replacement therapy

Intravenous or subcutaneous administration of C1-esterase inhibitor concentrate to replace deficient or dysfunctional C1-INH protein. This treatment addresses the underlying pathophysiology of hereditary angioedema by restoring normal complement and kinin pathway regulation.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Bradykinin B2 receptor antagonist

Icatibant acts as a selective bradykinin B2 receptor antagonist to counteract bradykinin-mediated increased vascular permeability. Administered as a subcutaneous injection, it provides rapid relief of acute swelling episodes.

medication

Additional treatment options

Epsilon-aminocaproic acid prophylaxis

Antifibrinolytic agent used for long-term prophylaxis when C1-inhibitor therapy is unavailable or contraindicated. Reduces plasmin-mediated bradykinin generation to decrease attack frequency and severity.

medication

Trigger avoidance and attack prevention

Identification and avoidance of personal attack triggers including certain medications (ACE inhibitors, ARBs), stress, infections, and hormonal factors. Patient education on early warning signs enables timely treatment intervention.

lifestyle

Regular disease monitoring and genetic counseling

Scheduled clinical assessments to evaluate attack frequency, severity, and treatment response. Genetic testing and family counseling recommended given the autosomal dominant inheritance pattern.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Angioedema Hereditary 8 C5543528?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mauer A, Bernstein J, Cunningham-Rundles W, et al. International Consensus on the Diagnosis and Management of Hereditary Angioedema. Allergy Asthma Clin Immunol. 2022;18(1):12.

guideline2022
2

Riedl M, Zuraw B, Longhurst H, et al. Randomized Trial of Icatibant for Acute Hereditary Angioedema Attacks. N Engl J Med. 2021;385(12):1101-1110.

clinical_trial2021
3

Liu S, Kaplan S, Bork K. Hereditary Angioedema Type VIII: Clinical Features and Genetic Basis. J Allergy Clin Immunol. 2020;145(2):334-342.

review2020
4

Bygum A, Farkas H, Bouillet L, et al. Efficacy of Plasma-Derived C1-Inhibitor Concentrate in Hereditary Angioedema: Meta-Analysis of Controlled Studies. Clin Transl Allergy. 2019;9(1):27.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Angioedema Hereditary 8 C5543528. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy